These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6140434)

  • 1. Mumps surveillance in England and Wales 1962-81.
    Galbraith NS; Young SE; Pusey JJ; Crombie DL; Sparks JP
    Lancet; 1984 Jan; 1(8368):91-4. PubMed ID: 6140434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of MMR vaccine on mumps infection in England and Wales.
    Jones AG; White JM; Begg NT
    CDR (Lond Engl Rev); 1991 Aug; 1(9):R93-6. PubMed ID: 1669792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of vaccination against mumps complications, Czech Republic, 2007-2012.
    Orlíková H; Malý M; Lexová P; Šebestová H; Limberková R; Jurzykowská L; Kynčl J
    BMC Public Health; 2016 Apr; 16():293. PubMed ID: 27036176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mumps surveillance in England and Wales supports introduction of two dose vaccination schedule.
    Gay N; Miller E; Hesketh L; Morgan-Capner P; Ramsay M; Cohen B; Brown D
    Commun Dis Rep CDR Rev; 1997 Feb; 7(2):R21-6. PubMed ID: 9046125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mumps epidemic--United kingdom, 2004-2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Feb; 55(7):173-5. PubMed ID: 16498380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current status of mumps and mumps vaccine in the United States.
    Hayden GF; Preblud SR; Orenstein WA; Conrad JL
    Pediatrics; 1978 Dec; 62(6):965-9. PubMed ID: 733425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health advice based on routine mumps surveillance in England and Wales.
    Yung C; Bukasa A; Brown K; Pebody R
    Euro Surveill; 2010 Sep; 15(38):. PubMed ID: 20929652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Why we need to continue to immunize against mumps.
    Gugelmann R
    Soz Praventivmed; 1995; 40(2):124-7. PubMed ID: 7747522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of surveillance of measles, mumps, and rubella in England and Wales: providing the platform for evidence-based vaccination policy.
    Vyse AJ; Gay NJ; White JM; Ramsay ME; Brown DW; Cohen BJ; Hesketh LM; Morgan-Capner P; Miller E
    Epidemiol Rev; 2002; 24(2):125-36. PubMed ID: 12762088
    [No Abstract]   [Full Text] [Related]  

  • 10. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A retrospective survey of the complications of mumps.
    the Association for the Study of Infectious Disease
    J R Coll Gen Pract; 1974 Aug; 24(145):552-6. PubMed ID: 4465449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Wide spread inflammation of the parotid glands (mumps): underestimated disease. I. Epidemiology of the mumps and its medical meaning in Poland].
    Gałazka A; Kraigher A; Robertson SE
    Przegl Epidemiol; 1998; 52(4):389-400. PubMed ID: 10321083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Australian vaccine preventable disease epidemiological review series: mumps 2008-2012.
    Bag SK; Dey A; Wang H; Beard F
    Commun Dis Intell Q Rep; 2015 Mar; 39(1):E10-8. PubMed ID: 26063086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006.
    Yung CF; Andrews N; Bukasa A; Brown KE; Ramsay M
    Emerg Infect Dis; 2011 Apr; 17(4):661-7; quiz 766. PubMed ID: 21470456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A; Boxall N; Amirthalingam G; Maddock L; Balasegaram S; Mindlin M
    Vaccine; 2014 Feb; 32(10):1147-52. PubMed ID: 24440207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the impact of measles vaccination in England and Wales: model validation and analysis of policy options.
    Babad HR; Nokes DJ; Gay NJ; Miller E; Morgan-Capner P; Anderson RM
    Epidemiol Infect; 1995 Apr; 114(2):319-44. PubMed ID: 7705494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of chickenpox in England and Wales, 1967-85.
    Joseph CA; Noah ND
    Br Med J (Clin Res Ed); 1988 Mar; 296(6623):673-6. PubMed ID: 3128363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of measles, mumps and rubella in Italy.
    Gabutti G; Rota MC; Salmaso S; Bruzzone BM; Bella A; Crovari P;
    Epidemiol Infect; 2002 Dec; 129(3):543-50. PubMed ID: 12558337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mumps in Poland in 2005].
    Stefanoff P
    Przegl Epidemiol; 2007; 61(2):195-8. PubMed ID: 17956031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.